Drug reference
Peripheral vascular disease ▶BY MOUTH ▶Adult: 100–200 mg 3 times a day, patients taking naftidrofuryl should be assessed for improvement after 3–6 months Cerebral vascular disease ▶BY MOUTH ▶Adult: 100 mg 3 times a day, patients taking naftidrofuryl should be assessed for improvement after 3–6 months
PDF page 269
NICE decisions ▶Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in Cardiovascular system people with peripheral arterial disease (May 2011) NICE TA223 Naftidrofuryl oxalate is an option for the treatment of intermittent claudication in patients with peripheral arterial disease in whom vasodilator therapy is considered appropriate. www.nice.org.uk/guidance/ta223
PDF page 270
▶Uncommon Diarrhoea. epigastric pain. nausea. rash. vomiting ▶Rare or very rare Liver injury. oxalate nephrolithiasis ▶Frequency not known Oesophagitis
PDF page 269
There can be variation in the licensing of different medicines containing the same drug. Forms available from special-order manufacturers include: oral solution Capsule CAUTIONARY AND ADVISORY LABELS 25, 27 ▶Naftidrofuryl oxalate (Non-proprietary) Naftidrofuryl oxalate 100 mg Naftidrofuryl 100mg capsules | 84 capsule P £7.50 DT = £5.26 ▶Praxilene (Merck Serono Ltd) Naftidrofuryl oxalate 100 mg Praxilene 100mg capsules | 84 capsule P £8.10 DT = £5.26
PDF page 270
100–200 mg 3 times a day, patients taking
First-line fragment. Read the complete Indications and Dose section above.
PDF page 269
100 mg 3 times a day, patients taking
First-line fragment. Read the complete Indications and Dose section above.
PDF page 269
